TEVA PHARMACEUTICAL INDS LTD's ticker is and the CUSIP is 881624909. A total of 8 filers reported holding TEVA PHARMACEUTICAL INDS LTD in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,714,260 | +7.4% | 756,300 | -20.7% | 0.03% | +13.0% |
| Q2 2023 | $7,182,867 | -38.4% | 953,900 | -27.6% | 0.02% | -45.2% |
| Q1 2023 | $11,652,795 | -71.5% | 1,316,700 | -70.6% | 0.04% | -55.8% |
| Q4 2022 | $40,824,768 | +2.7% | 4,476,400 | -9.1% | 0.10% | +21.8% |
| Q3 2022 | $39,739,000 | -21.5% | 4,924,300 | -26.8% | 0.08% | -1.3% |
| Q2 2022 | $50,619,000 | +13.0% | 6,731,200 | +41.1% | 0.08% | +79.5% |
| Q1 2022 | $44,808,000 | +21.6% | 4,771,900 | +3.7% | 0.04% | +46.7% |
| Q4 2021 | $36,861,000 | +138.8% | 4,601,900 | +190.3% | 0.03% | +76.5% |
| Q3 2021 | $15,439,000 | -23.7% | 1,585,100 | -22.5% | 0.02% | -29.2% |
| Q2 2021 | $20,244,000 | +5.2% | 2,044,800 | +22.6% | 0.02% | -17.2% |
| Q1 2021 | $19,250,000 | -3.2% | 1,668,100 | -19.1% | 0.03% | -14.7% |
| Q4 2020 | $19,893,000 | +130.7% | 2,061,500 | +115.4% | 0.03% | +25.9% |
| Q3 2020 | $8,622,000 | -42.7% | 956,900 | -21.6% | 0.03% | -60.9% |
| Q2 2020 | $15,055,000 | -14.3% | 1,221,000 | -37.6% | 0.07% | -51.7% |
| Q1 2020 | $17,577,000 | +0.8% | 1,957,300 | +10.0% | 0.14% | +20.2% |
| Q4 2019 | $17,436,000 | +60.1% | 1,779,200 | +12.4% | 0.12% | +35.2% |
| Q3 2019 | $10,894,000 | -38.1% | 1,583,400 | -17.0% | 0.09% | -44.7% |
| Q2 2019 | $17,608,000 | +106.9% | 1,907,700 | +251.5% | 0.16% | +67.4% |
| Q1 2019 | $8,510,000 | -64.6% | 542,700 | -65.2% | 0.10% | -54.3% |
| Q4 2018 | $24,031,000 | -14.8% | 1,558,400 | +19.0% | 0.21% | -6.7% |
| Q3 2018 | $28,202,000 | -24.8% | 1,309,300 | -15.1% | 0.22% | -30.5% |
| Q2 2018 | $37,497,000 | +95.7% | 1,541,800 | +37.5% | 0.32% | +66.3% |
| Q1 2018 | $19,163,000 | -63.9% | 1,121,300 | -60.0% | 0.19% | -48.3% |
| Q4 2017 | $53,098,000 | +100.4% | 2,802,000 | +86.1% | 0.37% | +54.8% |
| Q3 2017 | $26,500,000 | -9.9% | 1,505,700 | +70.0% | 0.24% | -21.2% |
| Q2 2017 | $29,416,000 | +47.9% | 885,500 | +42.9% | 0.31% | +32.5% |
| Q1 2017 | $19,883,000 | -61.0% | 619,600 | -55.9% | 0.23% | -53.2% |
| Q4 2016 | $50,946,000 | +377.5% | 1,405,400 | +506.0% | 0.49% | +325.9% |
| Q3 2016 | $10,670,000 | -18.9% | 231,900 | -11.5% | 0.12% | -25.6% |
| Q2 2016 | $13,160,000 | -7.9% | 262,000 | -1.8% | 0.16% | -22.8% |
| Q1 2016 | $14,282,000 | -40.3% | 266,900 | -26.8% | 0.20% | -28.6% |
| Q4 2015 | $23,926,000 | +2.7% | 364,500 | -11.7% | 0.28% | -12.1% |
| Q3 2015 | $23,295,000 | +135.2% | 412,600 | +146.2% | 0.32% | +131.7% |
| Q2 2015 | $9,905,000 | +95.1% | 167,600 | +105.6% | 0.14% | +73.8% |
| Q1 2015 | $5,077,000 | – | 81,500 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 100,000 | $1,020,000 | 0.66% |
| Capital Markets Trading UK LLP | 859,700 | $8,769 | 0.12% |
| GROUP ONE TRADING, L.P. | 756,300 | $7,714,260 | 0.03% |
| SIMPLEX TRADING, LLC | 1,308,000 | $13,341 | 0.01% |
| IMC-Chicago, LLC | 458,500 | $4,676,700 | 0.00% |
| JANE STREET GROUP, LLC | 1,331,500 | $13,581,300 | 0.00% |
| Clal Insurance Enterprises Holdings Ltd | 1,250 | $40 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |